GEHC

GE HealthCare Technologies
D

GEHC

Arincen60/100B
82.385
USD
-1.36
(-1.62%)
Post Trading·82.380USD-0.005(-0.01%)
Fair value76.47Plus+8%51Price 82.39119
Q4 FY2026 · Earnings report
EPS estimate 1.55Revenue estimate 5.92B
OverviewFinancialsForecastEarningsDividendsCompany

GE HealthCare Technologies EPS (earnings per share) 2019–2026

GE HealthCare Technologies's diluted EPS in Q3 FY2026, the three months to 30 September 2026, was 1.36 USD, up 38.8% on the same quarter a year before. GE HealthCare Technologies's diluted earnings per share over the last twelve months were 3.83 USD, down 20.9% on the twelve months before. In fiscal year 2025 they were 4.55 USD, up 4.8% on the year before.

Last updated 7 Nov 2026 · Next report 3 Feb 2027

EPS

Growth

Fiscal yearPeriod endingEPSGrowthEPS (basic)
TTM30 Sept 20263.83-20.87%3.86
FY202531 Dec 20254.55+4.84%4.56
FY202431 Dec 20244.34+43.71%4.37
FY202331 Dec 20233.02-28.44%3.04
FY202231 Dec 20224.22-13.88%4.22
FY202131 Dec 20214.90+11.11%4.90
FY202031 Dec 20204.41+31.64%4.41
FY201931 Dec 20193.35—3.35

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Income statement

Common questions about GE HealthCare Technologies's EPS

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.